Malcovati L - Search Results

1

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C, Travaglino E, Groves MJ, Godfrey AL, Ambaglio I, Gallì A, Da Vià MC, Conte S, Tauro S, Keenan N, Hyslop A, Hinton J, Mudie LJ, Wainscoat JS, Futreal PA, Stratton MR, Campbell PJ, Hellström-Lindberg E, Cazzola M; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium and of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative. Malcovati L, et al. Blood. 2011 Dec 8;118(24):6239-46. doi: 10.1182/blood-2011-09-377275. Epub 2011 Oct 12. Blood. 2011. PMID: 21998214 Free PMC article.

2

Hematologic passport for athletes competing in endurance sports: a feasibility study.

Malcovati L, Pascutto C, Cazzola M. Malcovati L, et al. Haematologica. 2003 May;88(5):570-81. Haematologica. 2003. PMID: 12745277

3

Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.

Passamonti F, Vanelli L, Malabarba L, Rumi E, Pungolino E, Malcovati L, Pascutto C, Morra E, Lazzarino M, Cazzola M. Passamonti F, et al. Among authors: malcovati l. Haematologica. 2003 Oct;88(10):1123-9. Haematologica. 2003. PMID: 14555308

4

Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders.

Passamonti F, Pietra D, Malabarba L, Rumi E, Della Porta MG, Malcovati L, Bonfichi M, Pascutto C, Lazzarino M, Cazzola M. Passamonti F, et al. Among authors: malcovati l. Br J Haematol. 2004 Sep;126(5):650-6. doi: 10.1111/j.1365-2141.2004.05098.x. Br J Haematol. 2004. PMID: 15327515 Free article.

5

Splenectomy for treatment of immune thrombocytopenic purpura.

Malcovati L, Della Porta MG. Malcovati L, et al. Haematologica. 2005 Jan;90(1):4. Haematologica. 2005. PMID: 15644305 No abstract available.

6

Myelodysplastic syndromes--coping with ineffective hematopoiesis.

Cazzola M, Malcovati L. Cazzola M, et al. Among authors: malcovati l. N Engl J Med. 2005 Feb 10;352(6):536-8. doi: 10.1056/NEJMp048266. N Engl J Med. 2005. PMID: 15703418 No abstract available.

7

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

Malcovati L, Della Porta MG, Lunghi M, Pascutto C, Vanelli L, Travaglino E, Maffioli M, Bernasconi P, Lazzarino M, Invernizzi R, Cazzola M. Malcovati L, et al. Leukemia. 2005 May;19(5):776-83. doi: 10.1038/sj.leu.2403680. Leukemia. 2005. PMID: 15789068 Clinical Trial.

8

Risk factors for Gram-negative infections in neutropenic patients.

Della Porta MG, Malcovati L. Della Porta MG, et al. Among authors: malcovati l. Haematologica. 2005 Aug;90(8):1013C. Haematologica. 2005. PMID: 16079097 No abstract available.

9

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

Malcovati L, Porta MG, Pascutto C, Invernizzi R, Boni M, Travaglino E, Passamonti F, Arcaini L, Maffioli M, Bernasconi P, Lazzarino M, Cazzola M. Malcovati L, et al. J Clin Oncol. 2005 Oct 20;23(30):7594-603. doi: 10.1200/JCO.2005.01.7038. Epub 2005 Sep 26. J Clin Oncol. 2005. PMID: 16186598

10

Outcome after allogeneic bone marrow transplantation in cytogenetic high-risk myelodysplastic syndromes and acute myeloid leukemia.

Della Porta MG, Malcovati L. Della Porta MG, et al. Among authors: malcovati l. Haematologica. 2005 Oct;90(10):1298C. Haematologica. 2005. PMID: 16219554 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters